METTL3 and colorectal cancer: In colorectal cancer, the reduction of METTL3 or METTL14 rises cytotoxic tumor-infiltrating CD8+ T cells and stimulates the recruitment of CD4+ and CD8+ effector T cells that suppress tumor growth38.